Citrulline a More Suitable Substrate than Arginine to Restore NO Production and the Microcirculation during Endotoxemia
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Impaired microcirculation during endotoxemia correlates with a disturbed arginine-nitric oxide (NO) metabolism and is associated with deteriorating organ function. Improving the organ perfusion in endotoxemia, as often seen in patients with severe infection or systemic inflammatory response syndrome (SIRS) is, therefore, an important therapeutic target. We hypothesized that supplementation of the arginine precursor citrulline rather than arginine would specifically increase eNOS-induced intracellular NO production and thereby improve the microcirculation during endotoxemia. METHODOLOGY/PRINCIPAL FINDINGS: To study the effects of L-Citrulline and L-Arginine supplementation on jejunal microcirculation, intracellular arginine availability and NO production in a non-lethal prolonged endotoxemia model in mice. C57/Bl6 mice received an 18 hrs intravenous infusion of endotoxin (LPS, 0.4 µg • g bodyweight(-1) • h(-1)), combined with either L-Citrulline (6.25 mg • h-1), L-Arginine (6.25 mg • h(-1)), or L-Alanine (isonitrogenous control; 12.5 mg • h(-1)) during the last 6 hrs. The control group received an 18 hrs sterile saline infusion combined with L-Alanine or L-Citrulline during the last 6 hrs. The microcirculation was evaluated at the end of the infusion period using sidestream dark-field imaging of jejunal villi. Plasma and jejunal tissue amino-acid concentrations were measured by HPLC, NO tissue concentrations by electron-spin resonance spectroscopy and NOS protein concentrations using Western blot. CONCLUSION/SIGNIFICANCE: L-Citrulline supplementation during endotoxemia positively influenced the intestinal microvascular perfusion compared to L-Arginine-supplemented and control endotoxemic mice. L-Citrulline supplementation increased plasma and tissue concentrations of arginine and citrulline, and restored intracellular NO production in the intestine. L-Arginine supplementation did not increase the intracellular arginine availability. Jejunal tissues in the L-Citrulline-supplemented group showed, compared to the endotoxemic and L-Arginine-supplemented endotoxemic group, an increase in degree of phosphorylation of eNOS (Ser 1177) and a decrease in iNOS protein level. In conclusion, L-Citrulline supplementation during endotoxemia and not L-Arginine reduced intestinal microcirculatory dysfunction and increased intracellular NO production, likely via increased intracellular citrulline and arginine availability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Due to this and its non-competitive uptake for cell transport [542], oral citrulline supplementation has been shown to be more effective in increasing arginine [543, 544] and activation of nitric oxide synthase (NOS) [544] as well as various biomarkers of nitric oxide [545].”
From ISSN exercise & sports nutrition review update: research & recommendations (2018) · cites this paper as [544]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide synthases: Roles, tolls, and controls
Nathan, C., & Xie, Q.-W. (1994) · Cell · doi:10.1016/0092-8674(94)90266-6 · Cited by 2,918 · cited 1×
“iNOS can produce excessive amounts of NO during endotoxemia, which contributes to the decreased arterial pressure and abnormal distribution of the blood flow in the microcirculation [18,23,24].”
BackgroundHow to evaluate the microcirculation: report of a round table conference
De Backer, D., Hollenberg, S., Boerma, C., Goedhart, P., Büchele, G., Ospina-Tascon, G., Dobbe, I., & Ince, C. (2007) · Critical Care · doi:10.1186/cc6118 · Cited by 830 · cited 6×
“Furthermore, the characteristics of the microcirculation according to de Backer et al [2,40,41] were analyzed using the Automated Vascular Analysis software 3.0 (Microscan, Amsterdam, The Netherlands).”
MethodInfluentialOrthogonal polarization spectral imaging: A new method for study of the microcirculation
Groner, W., Winkelman, J. W., Harris, A. G., Ince, C., Bouma, G. J., Messmer, K., & Nadeau, R. G. (1999) · Nature Medicine · doi:10.1038/13529 · Cited by 810 · cited 1×
“(SDF) imager [37,38].”
ARGINASE: A CRITICAL REGULATOR OF NITRIC OXIDE SYNTHESIS AND VASCULAR FUNCTION
Durante, W., Johnson, F. K., & Johnson, R. A. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04638.x · Cited by 577 · cited 2×
“Especially, enhanced activity of Arginase-1 [20,21] and iNOS (NOS2), but also diminished de novo arginine synthesis from citrulline and a diminished de novo citrulline synthesis are relevant mechanism which contribute to arginine deficiency [17,19,22].”
BackgroundMicrocirculatory oxygenation and shunting in sepsis and shock
Ince, C., & Sinaasappel, M. (1999) · Critical Care Medicine · doi:10.1097/00003246-199907000-00031 · Cited by 542 · cited 2×
“increase in inflammatory mediators [6,12–14].”
Nitroglycerin in septic shock after intravascular volume resuscitation
Spronk, P. E., Ince, C., Gardien, M. J., Mathura, K. R., Straaten, H. M. O.-V., & Zandstra, D. F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11393-6 · Cited by 541 · cited 1×
“(SDF) imager [37,38].”
Nitric oxide and intestinal inflammation
Kubes, P., & McCafferty, D.-M. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00480-0 · Cited by 347 · cited 1×
“iNOS can produce excessive amounts of NO during endotoxemia, which contributes to the decreased arterial pressure and abnormal distribution of the blood flow in the microcirculation [18,23,24].”
BackgroundRegulation of nitric oxide production in health and disease
Luiking, Y. C., Engelen, M. P., & Deutz, N. E. (2010) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328332f99d · Cited by 332 · cited 4×
“because the intracellular arginine does not increase during LArginine supplementation [15,22].”
BackgroundInfluentialThe Clinical Pharmacology of L-Arginine
Böger, R. H., & Bode-Böger, S. M. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.79 · Cited by 331 · cited 2×
“increased arginine plasma availability [26–30], hypothetically”
BackgroundBoerma, E. C., Mathura, K. R., van der Voort, P. H., Spronk, P. E., & Ince, C. (2005) · Critical Care · doi:10.1186/cc3809 · Cited by 308 · cited 6×
“time no flow, 2 = sludging, 3 = normal or 4 = hyperdynamic flow) [2].”
BackgroundMethodInfluentialRegulation of intestinal blood flow
Matheson, P. J., Wilson, M. A., & Garrison, R. N. (2000) · Journal of Surgical Research · doi:10.1006/jsre.2000.5862 · Cited by 296 · cited 1×
“increase in inflammatory mediators [6,12–14].”
L‐arginine‐induced vasodilation in healthy humans:pharmacokinetic–pharmacodynamic relationship
Bode‐Böger, S. M., Böger, R. H., Galland, A., Tsikas, D., & Frölich, J. C. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00803.x · Cited by 259
van Eijk, H. M. H., Rooyakkers, D. R., & Deutz, N. E. P. (1993) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/0378-4347(93)80062-9 · Cited by 252
Evaluation of sublingual and gut mucosal microcirculation in sepsis: A quantitative analysis*
Verdant, C. L., De Backer, D., Bruhn, A., Clausi, C. M., Su, F., Wang, Z., Rodriguez, H., Pries, A. R., & Vincent, J.-L. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181b029c1 · Cited by 236 · cited 5×
“Furthermore, the characteristics of the microcirculation according to de Backer et al [2,40,41] were analyzed using the Automated Vascular Analysis software 3.0 (Microscan, Amsterdam, The Netherlands).”
MethodInfluentialLuiking, Y. C., Poeze, M., Ramsay, G., & Deutz, N. E. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2007.25765 · Cited by 203 · cited 4×
“The effects of L-Citrulline supplementation: enhanced plasma arginine concentration and increased tissue arginine concentration may indicate that insufficient citrulline availability underlies the low arginine levels seen in endotoxemic mice [15,17,22].”
BackgroundInfluentialSelf-citationSepsis: An arginine deficiency state?
Luiking, Y. C., Poeze, M., Dejong, C. H., Ramsay, G., & Deutz, N. E. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000142939.81045.a0 · Cited by 170
Self-citationHollenberg, S. M., Broussard, M., Osman, J., & Parrillo, J. E. (2000) · Circulation Research · doi:10.1161/01.res.86.7.774 · Cited by 163 · cited 1×
“iNOS can produce excessive amounts of NO during endotoxemia, which contributes to the decreased arterial pressure and abnormal distribution of the blood flow in the microcirculation [18,23,24].”
BackgroundCitrulline modulates muscle protein metabolism in old malnourished rats
Osowska, S., Duchemann, T., Walrand, S., Paillard, A., Boirie, Y., Cynober, L., & Moinard, C. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00398.2005 · Cited by 150 · cited 1×
“[35,36].”
EVIDENCE FOR INTESTINAL AND LIVER EPITHELIAL CELL INJURY IN THE EARLY PHASE OF SEPSIS
Derikx, J. P. M., Poeze, M., van Bijnen, A. A., Buurman, W. A., & Heineman, E. (2007) · Shock · doi:10.1097/shk.0b013e3180644e32 · Cited by 138 · cited 1×
“increase in inflammatory mediators [6,12–14].”
Self-citationEndothelial nitric oxide production is tightly coupled to the citrulline–NO cycle
Flam, B. R., Eichler, D. C., & Solomonson, L. P. (2007) · Nitric Oxide · doi:10.1016/j.niox.2007.07.001 · Cited by 136 · cited 1×
“supplementation to increase intracellular endothelial arginine availability for NO production [16,22,27] and, thereby, to”
BackgroundGut dysfunction in critically ill patients: a review of the literature
Stechmiller, J., Treloar, D., & Allen, N. (1997) · American Journal of Critical Care · doi:10.4037/ajcc1997.6.3.204 · Cited by 113 · cited 1×
“tion and sepsis [9–11].”
Tain, Y., Hsieh, C., Lin, I.-C., Chen, C., Sheen, J., & Huang, L. (2010) · Nitric Oxide · doi:10.1016/j.niox.2010.03.005 · Cited by 110 · cited 1×
“[52–58].”
Smith, H. A. B., Canter, J. A., Christian, K. G., Drinkwater, D. C., Scholl, F. G., Christman, B. W., Rice, G. D., Barr, F. E., & Summar, M. L. (2006) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2006.02.012 · Cited by 107 · cited 2×
“[52–58].”
BackgroundHumane Endpoints for Infectious Disease Animal Models
Olfert, E. D., & Godson, D. L. (2000) · ILAR Journal · doi:10.1093/ilar.41.2.99 · Cited by 105 · cited 1×
“Contents of the score were based on the specific endpoints used in previous endotoxemia models in small laboratory animals of our group [31,32] and from the human endpoints for infectious animal models [33].”
MethodGoodwin, B. L., Solomonson, L. P., & Eichler, D. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308160200 · Cited by 100 · cited 1×
“This is supported by an in vitro study by Goodwin et al indicating intracellular arginine regeneration from citrulline, via the Ass pathway, to be essential for eNOS-mediated NO production in endothelial cells [50].”
ResultWaugh, W. H., Daeschner, C. W., Files, B., McConnell, M. E., & Strandjord, S. E. (2001) · PubMed Central · Cited by 95
Reduced arginine availability and nitric oxide production
Hallemeesch, M. M., Lamers, W. H., & Deutz, N. E. P. (2002) · Clinical Nutrition · doi:10.1054/clnu.2002.0571 · Cited by 86 · cited 2×
“However, no deficit in the plasma arginine pool, comparable to the metabolic derangements reported in man, was found in these acute models [22,45–48].”
BackgroundSelf-citationKoeners, M. P., van Faassen, E. E., Wesseling, S., de Sain-van der Velden, M., Koomans, H. A., Braam, B., & Joles, J. A. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.095794 · Cited by 85
Kaul, D. K., Zhang, X., Dasgupta, T., & Fabry, M. E. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00162.2008 · Cited by 80 · cited 1×
“[1–3], which makes organ perfusion an important therapeutic target [4,5].”
BackgroundBarr, F. E., Tirona, R. G., Taylor, M. B., Rice, G. D., Arnold, J., Cunningham, G. R., Smith, H. A. B., Campbell, A., Canter, J. A., Christian, K. G., et al. (2007) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2007.02.043 · Cited by 75 · cited 2×
“[52–58].”
BackgroundOrozco-Gutíerrez, J. J., Castillo‐Martínez, L., Orea‐Tejeda, A., Vázquez-Díaz, O., Valdespino-Trejo, A. A., Narváez-David, R., Keirns‐Davis, C., Carrasco-Ortiz, O., Navarro‐Navarro, A., & Sánchez‐Santillán, R. (2010) · PubMed · Cited by 74
Bruins, M. J., Soeters, P. B., Lamers, W. H., Meijer, A. J., & Deutz, N. E. P. (2002) · Critical Care Medicine · doi:10.1097/00003246-200203000-00003 · Cited by 65 · cited 1×
“Arginine deficiency in inflammatory conditions has led to several experimental and human studies investigating modalities to restore the arginine-induced NO production [28–30,49].”
BackgroundSelf-citationQuantitative analysis of small intestinal microcirculation in the mouse
Maßberg, S., Eisenmenger, S., Enders, G. A., Krombach, F., & Messmer, K. (1998) · Research in Experimental Medicine · doi:10.1007/s004330050086 · Cited by 63 · cited 1×
“[39] who used intravital fluorescence microscopy to evaluate the mucosal jejunal micro-”
MethodIleal V o 2–D o 2 Alterations Induced by Endotoxin Correlate with Severity of Mitochondrial Injury
Crouser, E. D., JULIAN, M. W., & Dorinsky, P. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.4.9810116 · Cited by 63 · cited 1×
“[1–3], which makes organ perfusion an important therapeutic target [4,5].”
BackgroundShen, L., Beloussow, K., & Shen, W. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.09.003 · Cited by 60 · cited 3×
“[27] reported that citrulline is the major arginine pool for eNOSmediated NO production, while extracellular arginine forms the only arginine pool for iNOS-induced NO production [27].”
BackgroundEffect of Endotoxemia on Intestinal Villus Microcirculation in Rats
Schmidt, H., Secchi, A., Wellmann, R., Bach, A., Bohrer, H., Gebhard, M. M., & Martin, E. (1996) · Journal of Surgical Research · doi:10.1006/jsre.1996.0157 · Cited by 60 · cited 1×
“tion and sepsis [9–11].”
Krejčí, V., Hiltebrand, L. B., Erni, D., & Sigurdsson, G. H. (2003) · Critical Care Medicine · doi:10.1097/00003246-200301000-00031 · Cited by 56
Arginase blockade protects against hepatic damage in warm ischemia-reperfusion
Jeyabalan, G., Klune, J. R., Nakao, A., Martik, N., Wu, G., Tsung, A., & Geller, D. A. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.04.002 · Cited by 53 · cited 2×
“Especially, enhanced activity of Arginase-1 [20,21] and iNOS (NOS2), but also diminished de novo arginine synthesis from citrulline and a diminished de novo citrulline synthesis are relevant mechanism which contribute to arginine deficiency [17,19,22].”
BackgroundPittner, A., Nalos, M., Asfar, P., Yang, Y., İnce, C., Georgieff, M., Brückner, U. B., Radermacher, P., & Fröba, G. (2003) · Intensive Care Medicine · doi:10.1007/s00134-002-1577-y · Cited by 50 · cited 1×
“increase in inflammatory mediators [6,12–14].”
İnce, C. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2204033 · Cited by 50 · cited 1×
“[1–3], which makes organ perfusion an important therapeutic target [4,5].”
BackgroundLuiking, Y. C., Hallemeesch, M. M., Vissers, Y. L. J., Deutz, N. E. P., & Lamers, W. H. (2004) · Journal of Nutrition · doi:10.1093/jn/134.10.2768s · Cited by 44 · cited 2×
“However, no deficit in the plasma arginine pool, comparable to the metabolic derangements reported in man, was found in these acute models [22,45–48].”
BackgroundSelf-citationHartman, W. J., Torre, P. M., & Prior, R. L. (1994) · Journal of Nutrition · doi:10.1093/jn/124.10.1950 · Cited by 36 · cited 1×
“In addition, the therapeutic role of L-Citrulline is not limited to endotoxemic conditions, as LCitrulline supplementation has been demonstrated to be beneficial in several other pathological conditions associated with limited L-Arginine availability or enhanced arginine catabolism [51–54].”
BackgroundEndotoxemia affects citrulline, arginine and glutamine bioavailability
Elwafi, F. Z., Curis, E., Zerrouk, N., Neveux, N., Chaumeil, J., Arnaud, P., Cynober, L., & Moinard, C. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02581.x · Cited by 34 · cited 1×
“Such a therapeutic role of L-Citrulline supplementation is also supported by very recent data of Elwafi et al [36], who showed that oral supplementation of L-Citrulline in rats resulted in higher plasma arginine concentrations compared to L-Arginine supplementation during acute endotoxemia [36].”
ResultChen, K., Inoue, M., Wasa, M., Fukuzawa, M., Kamata, S., & Okada, A. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00677-2 · Cited by 34 · cited 2×
“in the microcirculatory disturbances in sepsis [25].”
BackgroundPoeze, M., Bruins, M. J., Kessels, F., Luiking, Y. C., Lamers, W. H., & Deutz, N. E. P. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.007237 · Cited by 33 · cited 2×
“In addition, also in a model of prolonged porcine endotoxemia, whole-body NO production was not increased during L-Arginine supplementation [34].”
BackgroundMethodSelf-citationFukatsu, K., Ueno, C., Maeshima, Y., Hara, E., Nagayoshi, H., Omata, J., Mochizuki, H., & Hiraide, H. (2004) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607104028004224 · Cited by 30 · cited 2×
“increased arginine plasma availability [26–30], hypothetically”
BackgroundTime course of nitric oxide production after endotoxin challenge in mice
Bráulio, V. B., Have, G. A. M. T., Vissers, Y. L. J., & Deutz, N. E. P. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00540.2003 · Cited by 29 · cited 2×
“Our new model was based on a pilot observation in mice that plasma arginine concentrations decreased below baseline from 12 hours after the onset of the continuous endotoxin infusion, which is supported by the observations of Braulio et al [31].”
MethodOrea‐Tejeda, A., Orozco-Gutíerrez, J. J., Castillo‐Martínez, L., Keirns-Davies, C., Montaño-Hernández, P., Vázquez-Díaz, O., Valdespino-Trejo, A. A., Infante, Ó., & Martínez‐Memije, R. (2010) · PubMed · Cited by 29
Detection of basal NO production in rat tissues using iron–dithiocarbamate complexes
van Faassen, E. E., Koeners, M. P., Joles, J. A., & Vanin, A. F. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.02.003 · Cited by 28
Effect of Prolonged Hyperdynamic Endotoxemia on Jejunal Motility in Fasted and Enterally Fed Pigs
Bruins, M. J., Luiking, Y. C., Soeters, P. B., Akkermans, L. M. A., & Deutz, N. E. P. (2003) · Annals of Surgery · doi:10.1097/00000658-200301000-00007 · Cited by 23 · cited 1×
“tion and sepsis [9–11].”
Luiking, Y. C., Hallemeesch, M. M., van de Poll, M. C., Dejong, C. H. C., de Jonge, W. J., Lamers, W. H., & Deutz, N. E. P. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00055.2008 · Cited by 20 · cited 4×
“because the intracellular arginine does not increase during LArginine supplementation [15,22].”
BackgroundInfluentialSelf-citationReduced caloric intake during endotoxemia reduces arginine availability and metabolism
Poeze, M., Bruins, M. J., Luiking, Y. C., & Deutz, N. E. P. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27812 · Cited by 20 · cited 1×
“We, therefore, consider that this prolonged endotoxemia model mimics the human metabolic situation during endotoxemia-induced inflammatory conditions, in which we demonstrated a deficiency in arginine availability and associated decreased NO production during prolonged endotoxemia [44].”
BackgroundSelf-citationRenal Amino Acid Metabolism during Endotoxemia in the Rat
Hallemeesch, M. M., Cobben, D., Dejong, C. H. C., Soeters, P. B., & Deutz, N. E. P. (2000) · Journal of Surgical Research · doi:10.1006/jsre.2000.5867 · Cited by 17 · cited 1×
“Contents of the score were based on the specific endpoints used in previous endotoxemia models in small laboratory animals of our group [31,32] and from the human endpoints for infectious animal models [33].”
MethodPros and cons of L-arginine supplementation in disease
Vissers, Y. L. J., Debats, I. B. J. G., Luiking, Y. C., Jalan, R., van der Hulst, R. R. W. J., Dejong, C. H. C., & Deutz, N. E. P. (2004) · Nutrition Research Reviews · doi:10.1079/nrr200490 · Cited by 16 · cited 1×
“increased arginine plasma availability [26–30], hypothetically”
Adaptative response of nitrogen metabolism in early endotoxemia: role of ornithine aminotransferase
Ventura, G., Moinard, C., Segaud, F., Plénier, S. L., Cynober, L., & Bandt, J. P. D. (2010) · Amino Acids · doi:10.1007/s00726-010-0601-8 · Cited by 13 · cited 1×
“It should however be mentioned that one experimental animal study reported significant changes in the arginine flux in the early stages of endotoxemia [48].”
BackgroundHepatic and splanchnic microvascular responses to inflammation and shock.
Rs, M. (1999) · PubMed · Cited by 13
The role of NOS2 and NOS3 in renal protein and arginine metabolism during early endotoxemia in mice
Luiking, Y. C., Hallemeesch, M. M., Lamers, W. H., & Deutz, N. E. P. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00308.2004 · Cited by 8 · cited 2×
“However, no deficit in the plasma arginine pool, comparable to the metabolic derangements reported in man, was found in these acute models [22,45–48].”
BackgroundSelf-citationPathophysiology of ischaemia-reperfusion injury
Carden, D. L., & Granger, D. N. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200002)190:3 · Cited by 5
Research works printed but not linked: 1
- HA Lehr, 2000, Microcirculatory dysfunction in sepsis: a pathogenetic basis for therapy?, J Pathol, 190, 373, 10.1002/(SICI)1096-9896(200002)190:3<373::AID-PATH593>3.0.CO;2-3 · doi:10.1002/(sici)1096-9896(200002)190:3<373::aid-path593>3.0.co;2-3
Cited by
ISSN exercise & sports nutrition review update: research & recommendations
Kerksick, C. M., Wilborn, C. D., Roberts, M. D., Smith-Ryan, A., Kleiner, S. M., Jäger, R., Collins, R., Cooke, M., Davis, J. N., Galvan, E., et al. (2018) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-018-0242-y · Cited by 945
Nitric oxide synthase in innate and adaptive immunity: an update
Bogdan, C. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.01.003 · Cited by 862
l-Citrulline Supplementation: Impact on Cardiometabolic Health
Allerton, T., Proctor, D., Stephens, J., Dugas, T., Spielmann, G., & Irving, B. (2018) · Nutrients · doi:10.3390/nu10070921 · Cited by 231
“This is further supported by in vivo models of sepsis where L-citrulline supplementation induces selective reductions in pro-inflammatory cytokines (IL-6) but preserves anti-inflammatory cytokine (IL-10) production [72] and NO production [73].”
BackgroundArginine and Citrulline and the Immune Response in Sepsis
Wijnands, K., Castermans, T., Hommen, M., Meesters, D., & Poeze, M. (2015) · Nutrients · doi:10.3390/nu7031426 · Cited by 207
“decreased arginine concentrations in murine endotoxemia and in septic ICU patients [3,132].”
BackgroundInfluentialSelf-citationCitrulline and nitrogen homeostasis: an overview
Breuillard, C., Cynober, L., & Moinard, C. (2015) · Amino Acids · doi:10.1007/s00726-015-1932-2 · Cited by 170
Metadata
- Authors
- Wijnands, K. A. P., Vink, H., Briedé, J. J., van Faassen, E. E., Lamers, W. H., Buurman, W. A., & Poeze, M.
- Affiliations
- Maastricht University Medical Centre (NL)
- Corresponding author
- Wijnands, Karolina A. P.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-05-29
- Volume
- 7
- Issue
- 5
- Pages
- e37439
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3362574
- OpenAlex
- W1972157068
- Cited by
- 136
- References
- 58
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 7 · 2023: 7 · 2022: 5 · 2021: 13 · 2020: 7 · 2019: 18 · 2018: 18 · 2017: 9 · 2016: 9 · 2015: 12 · 2014: 12 · 2013: 9 · 2012: 2
- FWCI
- 7.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, cc-by)
- Pure Amsterdam UMC (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Research Publications (Maastricht University) (submittedVersion, cc-by)
- Funders
- Eli Lilly and Company
- ZonMw (VENI 916.76.191)
- European Society of Intensive Care Medicine
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
- Keywords
- citrulline, L-arginine, endotoxemia, nitric oxide production, endothelial nitric oxide synthase, inducible nitric oxide synthase, intestinal microcirculation, systemic inflammatory response syndrome, arginine metabolism, LPS, jejunal villi, amino acid supplementation, organ perfusion, sepsis, iNOS inhibition
- MeSH terms
- Animals, Arginine, Biological Availability, Citrulline, Male, Mice, Inbred C57BL, Microcirculation, Nitric Oxide, Gene Expression Regulation, Enzymologic, Endotoxemia, Dietary Supplements, Intracellular Space, Mice, Nitric Oxide Synthase Type II, Nitric Oxide Synthase Type III
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.